d-Cycloserine enhances implicit memory in Alzheimer patients
- 1 February 1996
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 46 (2), 420-424
- https://doi.org/10.1212/wnl.46.2.420
Abstract
We tested the ability of d-cycloserine, a partial glycine agonist acting at the N-methyl-D-aspartate (NMDA) receptor complex, to improve implicit memory in Alzheimer patients in a parallel-group, placebo-controlled, double-blind study. One-hundred eight patients with probable Alzheimer's disease of mild to moderate severity received d-cycloserine (5, 15, or 50 mg) or placebo twice daily for 10 weeks. We then evaluated their ability to identify perceptually degraded words, some of which were repeated over multiple trials across 3 days. Implicit memory performance of words repeated across trials was significantly enhanced for the patients who received 15 mg d-cycloserine compared with those who received placebo. These findings support development of NMDA receptor-mediated glutamatergic interventions for the treatment of Alzheimer-related memory disorders. NEUROLOGY 1996;46: 420-424Keywords
This publication has 6 references indexed in Scilit:
- Hippocampus-dependent learning facilitated by a monoclonal antibody or D-cycloserineNature, 1992
- Activation of the hippocampus in normal humans: a functional anatomical study of memory.Proceedings of the National Academy of Sciences, 1992
- Cerebral control for speech in right-handers and left-handers: An analysis of the views of Paul Borca, his contemporaries, and his successorsBrain and Language, 1991
- On the production of neurologists in the United StatesNeurology, 1991
- Social adjustment and psychopathology among formerly hospitalized and non-hospitalized mothers—I. Development of the social role adjustment instrumentJournal of Psychiatric Research, 1975
- Brain Research and Violent BehaviorArchives of Neurology, 1974